Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria

201554 citationsJournal Articlehybrid Open Access

Authors

Henk‐Frans Kwint · SIR Institute for Pharmacy Practice and Policy

Adrianne Faber · SIR Institute for Pharmacy Practice and Policy

Jacobijn Gussekloo · Leiden University Medical Center

Marcel L. Bouvy · SIR Institute for Pharmacy Practice and Policy

Abstract

This study shows that the majority of drug-related problems of community-dwelling older patients was not associated with STOPP/START criteria. These findings suggest that application of STOPP/START criteria in full clinical medication review should preferably be combined with implicit criteria.

Topics & Keywords

Pharmaceutical Practices and Patient Outcomes Health Systems, Economic Evaluations, Quality of Life Patient Safety and Medication Errors

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Journal of Clinical Pharmacology

Volume 71, Issue 10, pp. 1255-1262

DOI: 10.1007/s00228-015-1908-x

Field-Weighted Citation Impact: 4.30

Command Palette